 SAINT LAURENT, Quebec, May 11, 2021 GLOBE NEWSWIRE -- IntelGenx Technologies Corp. TSX-V:IGX OTCQB:IGXT IntelGenx, a leader in pharmaceutical films, today announced that a significant majority of its shareholders have approved the resolution approving the previously announced investment in IntelGenx by ATAI Life Sciences AG atai, pursuant to which atai will initially acquire an approximate 25 interest in IntelGenx. 